Rivaroxaban
- PDF / 169,682 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 93 Downloads / 153 Views
1 S
Rivaroxaban Lower digestive haemorrhage following an inadvertent administration of rivaroxaban by the patient herself: case report
In a study of 8 patients who had undergone laparoscopic vertical gastrectomy between January 2011 and December 2018, a female patient [age not stated] was described, who developed a lower digestive haemorrhage following an inadvertent administration of rivaroxaban by the patient herself. The female patient, who had grade III obesity, underwent laparoscopic vertical gastrectomy. She received enoxaparin sodium [enoxaparin] prophylaxis throughout the admission which was extended for a further 2 weeks after the discharge. However, she developed a post-operative complication of portal vein thrombosis. Consequently, she was transferred to the ICU and treated with heparin [unfractionated heparin]. Following improvement in the portal vein thrombosis, heparin was replaced by warfarin [warfarin sodium] and she was discharged. She received warfarin for 6 months. After using warfarin for 6 months, she inadvertently replaced warfarin by rivaroxaban by herself [dosage and route not stated]. She developed a lower digestive haemorrhage due to inadvertent administration of rivaroxaban by the patient herself [duration of treatment to reaction onset not stated]. As a result, the female patient was hospitalised. She received blood products and rivaroxaban was replaced by warfarin. Her lower digestive haemorrhage stopped. She did not suffer any further adverse events or need surgical reintervention. Filho JODR, et al. Portal vein thrombosis in laparoscopic vertical gastrectomy - laparoscopic sleeve gastrectomy: A case series. Jornal Vascular Brasileiro 19: 1-5, 2020. 803519840 Available from: URL: http://doi.org/10.1590/1677-5449.200013
0114-9954/20/1834-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 12 Dec 2020 No. 1834
Data Loading...
